Alembic Pharmaceuticals (Alembic) announced that it has received Final Approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Diltiazem ...

The approved strengths for the said drug are 120 mg, 180 mg, 240 mg, 300 mg, and 360 mg. Diltiazem Hydrochloride Extended-Release (ER) capsules are indicated for the treatment of hypertension.

Diltiazem Hydrochloride Extended-Release Capsules USP are indicated for the treatment of hypertension. (Image Credits: Pixabay) Alembic Pharmaceuticals Limited on Monday announced that it has ...

Join us from November 5-7, as we showcase our capabilities across the oil and gas value chain and share insights on achieving operational resilience and unlocking value through digital innovation.

The HCL journey has been relentless, gratifying and marked with a series of achievements. Our unified efforts have catapulted the company from a garage start-up to a conglomerate whose businesses span ...

Bonus Dec 05, 2019 Dec 07, 2019 Oct 23, 2019 Bonus Ratio: 1 share(s) for every 1 shares held Bonus Mar 19, 2015 Mar 20, 2015 Jan 30, 2015 Bonus Ratio: 1 share(s) for every 1 shares held Bonus Mar 15, ...

You also acknowledge and agree that your employment with HCL is subject to your receiving a clean background verification report. HCL reserves the right to revoke your offer and/or terminate your ...

When patients use non-ER facilities, it's less costly for the insurer, and that translates into lower overall healthcare cost—and lower insurance premiums—for everyone. But in the case of a life- or ...

Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of ...